secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001213900-24-069941
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics announces 1-for-15 reverse stock split effective Aug 20, 2024
--------------------------------------------------------------------------------

- Reverse stock split ratio set at 1-for-15; effective at 12:01 a.m. ET on August 20, 2024.
- Outstanding shares reduced from ~16M to ~1.1M; no fractional shares; cash paid in lieu.
- New CUSIP number 127636 207; stock continues trading under CVKD on Nasdaq.
- Split intended to regain compliance with Nasdaq minimum $1.00 bid price requirement.
- Proportional adjustments made to equity awards, warrants, and exercise prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024069941/0001213900-24-069941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024069941/ea021156901-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-069941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer